ResMed | RMD - Ebit

Stock Price
37.46
Daily Change
1.75 4.90%
Monthly
3.82%
Yearly
-3.18%
Q1 Forecast
36.78

ResMed reported $497.6M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
Ansell USD 117.3M 39.1M Jun/2024
Avita Medical AUD -8.66M 1.61M Jun/2025
Cochlear AUD 275M 25.5M Dec/2024
CSL USD 2.75B 1.35B Dec/2024
Fisher & Paykel Healthcare NZD 298.2M 2.8M Dec/2025
Healius AUD 23.7M 26M Dec/2024
Integral Diagnostics AUD 24.99M 5.08M Jun/2024
Mayne Pharma AUD -16.2M 13.2M Jun/2024
Nanosonics AUD 8.7M 2.6M Dec/2024
Polynovo AUD 840K 147K Jun/2024
Ramsay Health Care AUD 500.1M 14.8M Dec/2024
Regis Healthcare AUD 44.36M 13.1M Dec/2024
ResMed USD 497.6M 35.25M Dec/2025
Sigma Healthcare AUD 809K 13.76M Dec/2024
Sonic Healthcare AUD 423.94M 80.3M Dec/2024
Telix Pharmaceuticals AUD 37.44M 16.38M Dec/2024